[Clinical manifestation of hepatotoxic effect of cytostatic chemicals].
Polunina
T E
TE
Maev
I V
IV
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology* / Q000473:pathology; D002756:Cholagogues and Choleretics / Q000627:therapeutic use; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008111:Liver Function Tests; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
D000964:Antimetabolites, Antineoplastic; D002756:Cholagogues and Choleretics; D014580:Ursodeoxycholic Acid; D015122:Mercaptopurine